Does Maca Hot Flashes Randomized Trial work?

Updated July 2026

Quick Answer

Maca Hot Flashes Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Background: Middle-aged women frequently experience diverse physical and psychological symptoms, including depression, anxiety, sleep disturbances, vasomotor symptoms, and reduced quality of life, during menopause.

Key Takeaways

  • 01Background: Middle-aged women frequently experience diverse physical and psychological symptoms, including depression, anxiety, sleep disturbances, vasomotor symptoms, and reduced quality of life, during menopause. [Kim JH (2025)]
  • 02Risk of bias was assessed using the Cochrane risk of bias tool, and meta-analyses were performed using a random effects model. [Kim JH (2025)]
  • 03Results: Nonpharmacological interventions significantly reduced symptoms of depression (standardized mean difference (SMD) = -1.10), anxiety (-0.82), sleep disturbances (-0.90), menopausal symptoms (-1.18), and hot flashes (-0.34). [Kim JH (2025)]
  • 04With increasing concerns regarding the side effects of hormone therapy, nonpharmacological interventions have emerged as safer alternatives for symptom management. [Kim JH (2025)]
The current Migaku evidence database contains 2 reusable source documents for Maca Hot Flashes Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - Background: Middle-aged women frequently experience diverse physical and psychological symptoms, including depression, anxiety, sleep disturbances, vasomotor symptoms, and reduced quality of life, during menopause. [Kim JH (2025); evidence level 1] - Risk of bias was assessed using the Cochrane risk of bias tool, and meta-analyses were performed using a random effects model. [Kim JH (2025); evidence level 1] - Results: Nonpharmacological interventions significantly reduced symptoms of depression (standardized mean difference (SMD) = -1.10), anxiety (-0.82), sleep disturbances (-0.90), menopausal symptoms (-1.18), and hot flashes (-0.34). [Kim JH (2025); evidence level 1] - With increasing concerns regarding the side effects of hormone therapy, nonpharmacological interventions have emerged as safer alternatives for symptom management. [Kim JH (2025); evidence level 1] - Results The mean score of decision conflict [Mean difference (MD): -2.07, 95% CI: -29.65 to -11.92, P = 0.001] and decision regret [MD: -1.25, 95% CI: -1.64 to 0.64, P = 0.03] significantly reduced in the intervention group compared to the control group after the intervention. [Ghehi LM (2025); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Nonpharmacological Intervention Effects on Middle-Aged Women with Menopausal Symptoms: A Systematic Review and Meta-Analysis.
  2. The effect of shared decision-making on the conflict and regret in menopause symptoms management: an interventional study.